GAGE7 (G antigen 7) is a cancer/testis antigen encoded on the X chromosome X shows selective expression in malignant tumors and normal germline tissues. 1 GAGE7 is expressed in various human cancers, with demonstrated immunogenicity as a target for CD8+ cytolytic T lymphocytes. 1 In breast carcinoma, GAGE7 exhibits heterogeneous subcellular localization patterns (nuclear, cytoplasmic, and nucleolar), with cytoplasmic expression significantly associated with advanced clinical stages. 2 Coexpression of GAGE7 with other cancer/testis antigens correlates with poor prognosis. 2 GAGE7 serves as a valuable diagnostic biomarker for spermatocytic seminoma, with 67% sensitivity and 99% specificity when using stringent criteria, substantially outperforming detection in other germ cell tumors. 3 In lung cancer screening, anti-GAGE7 autoantibodies demonstrate high specificity and represent a component of multi-autoantibody panels. 4 5 Individual anti-GAGE7 antibody detection shows 11.3% positivity in early non-small cell lung cancer versus 0.5% in controls. 6 When combined with other autoantibodies and imaging, GAGE7-based panels improve diagnostic accuracy for malignant pulmonary nodules. 7 These findings establish GAGE7 as a clinically relevant tumor-associated antigen with prognostic and diagnostic applications across multiple cancer types.